Senex, el vell savi : Estudi del reconeixement del papa el 750

Breu assaig de caràcter hermenèutic on l'autor es proposa una lectura d'un esdeveniment històric particular. L'autor pren com a excusa per a la seva interpretació dels esdeveniments els fets que tingueren lloc el 750 al bell mig del regne franc quan els merovingis reconeixen explícitament la figura d'autoritat del papa en la comunitat cristiana occidental i com el papa l'assumeix pròpiament.

Adaptabilidade e estabilidade de populações de milho-pipoca

A identificação de cultivares com maior estabilidade torna o processo de recomendação de cultivares mais seguro. O objetivo deste trabalho foi avaliar a adaptabilidade e estabilidade de oito populações de milho-pipoca quanto a produtividade e capacidade de expansão em dois locais no norte do Estado do Paraná. As populações e a testemunha (ZÉLIA) foram avaliadas em Londrina e Faxinal em dois anos agrícolas, utilizando delineamento experimental de blocos ao acaso com três repetições. Na análise de variância, consideraram-se os parâmetros de produtividade e capacidade de expansão e a adaptabilidade e estabilidade foram estimadas com base no modelo proposto por Eberhart e Russell. O híbrido ZÉLIA e as populações UEL PAPA, UE PASHA, UEL PO, UEL PAMPGA, UEL PAPCB e UEL PAPYY apresentaram os melhores resultados de produtividade, 3.203,50, 3.733,41, 3.512,08, 3.176,25, 2.847,49, 2.764,75 e 2.421,66 kg ha-1 e capacidade de expansão 27,68, 25,05, 27,41, 27,17, 27,64, 28,60 e 27,36, respectivamente, apresentando comportamento previsível para o cultivo com baixos riscos na região.

Le Clou de l'exposition de 1900 : notre musée des souverains n° IV, la Princesse Jolie-Mine : Wilhelmine : notre musée des souverains n° XI : [impression photomécanique] / Jean Veber

Collection : Le Rire ; 140

BRS Guamirim: cultivar de trigo da classe pão, precoce e de baixa estatura

A cultivar de trigo BRS Guamirim foi desenvolvida pela Embrapa e resultou de um cruzamento entre os genitores Embrapa 27/Buck Nandu e PF 93159. Possui ciclo precoce, baixa estatura de planta e intenso afilhamento. Apresenta equilibrada reação às principais moléstias do trigo, pertence à classe pão e demonstra adaptabilidade às diferentes regiões tritícolas do país, com estabilidade de produção. Seu potencial de rendimento é superior a 5 t ha-1.

Embankment Quality Phase IV: Application to Unsuitable Soils, TR-492, 2007

The Quality Management Earthwork (QM-E) special provision was implemented on a pilot project to evaluate quality control (QC) and quality assurance (QA) testing in predominately unsuitable soils. Control limits implemented on this pilot project included the following: 95% relative compaction, moisture content not exceeding +/- 2% of optimum moisture content, soil strength not exceeding a dynamic cone penetrometer (DCP) index of 70 mm/blow, vertical uniformity not exceeding a variation in DCP index of 40 mm/blow, and lift thickness not exceeding depth determined through construction of control strips. Four-point moving averages were used to allow for some variability in the measured parameter values. Management of the QC/QA data proved to be one of the most challenging aspects of the pilot project. Implementing use of the G-RAD data collection system has considerable potential to reduce the time required to develop and maintain QC/QA records for projects using the QM-E special provision. In many cases, results of a single Proctor test were used to establish control limits that were used for several months without retesting. While the data collected for the pilot project indicated that the DCP index control limits could be set more tightly, there is not enough evidence to support making a change. In situ borings, sampling, and testing in natural unsuitable cut material and compacted fill material revealed that the compacted fill had similar strength characteristics to that of the natural cut material after less than three months from the start of construction.

Calmodulin kinase IV: expression and function during rat brain development.

The expression of calmodulin kinase IV (CaMKIV) can be induced by the thyroid hormone T3 in a time- and concentration-dependent manner at a very early stage of brain differentiation using a fetal rat telencephalon primary cell culture system which can grow and differentiate under chemically defined conditions (Krebs et al. (1996) J. Biol. Chem. 271, 11055-11058). After the induction of CaMKIV by T3 we examined the influence of prolonged absence of T3 from the culture medium on the expression of CaMKIV. We could demonstrate that after the T3-dependent induction of CaMKIV, omission of the hormone, even for 8 days, from the medium did not downregulate the expression of CaMKIV indicating that different regulatory mechanisms became important for the expression of the enzyme. We further showed that CaMKIV could be involved in the Ca(2+) -dependent expression of the immediate early gene c-fos, probably via phosphorylation of the transcription factor CREB. Convergence of signal transduction pathways on this transcription factor by using different protein kinases may explain the importance of CREB for the regulation of different cellular processes.

Treatment of osteitis pubis with on single iv injection of Ibandronate: report of two cases

Objectives: Osteitis pubis is a noninfectious painfulinflammatory disorder of the symphysis pubis. Etiologicfactors are numerous, the most common are: osseousextension of adductor enthesis due to sport overuse,irritation after urological and abdominal procedures, andsystemic inflammatory disorders in particular spondylarthropathies.Many cases are idiopathic. The symptomsconsist of regional chronic mechanical and sometimenocturnal pain. Diagnosis is usually confirmed by eitherbone scintigraphy or by MRI. There are no standardtreatments but conservative approaches including rest andNSAIDS are generally recommended. In 2001, a goodclinical and radiological response of three refractory caseswith 3-6 monthly perfusions of pamidronate was reported(1). Ibandronate is a much more powerful and long-lastingbisphosphonate than pamidronate, and has not yet beenreported in literature to our knowledge in this indication.Materials/Methods: We present two cases of idiopathicorigin: one woman (63 years old) and one man (36 yearsold).The symptoms were present >3 months in the firstpatient and 1 year in the second. The diagnosis wasconfirmed by MRI which showed bone edema on bothsizes of symphysis and in the second case bony erosionsadjacent to the joint were seen. Both cases failed to respondto conservative measures. Both patients received one singledirect iv Injection of 3 mg of Ibandronate.Results: The injections resulted in a rapid (within a fewdays) resolution of pain that lasted more than 6 months inboth patients. No side effects were observed. In the firstcase, an isotope bone scan performed 4 months after theinjection showed no residual uptake. The second patienthad a repeated MRI after 6 months. It demonstrated anattenuation of bone edema compared to the first MRI.Conclusions: IV Ibandronate may constitute a safe andeffective treatment option for patients with refractoryosteitis pubis.Reference: 1: Maksymowych WP, Aaron SL, Russell AS, JRheumatol 28:2754, 2001.Disclosure of Interest: None declared.

Correspondance : 1812-1876. IV. 1854-1863 / George Sand

Collection : Bibliothèque contemporaine

Noves aportacions al coneixement florístic de l’Empordà - IV = A new contribution to the flora of the Empordà (Catalonia, NE Iberian Peninsula) - IV

En el decurs de les prospeccions florístiques realitzades en els darrers tres anys a les comarques de l’Alt i Baix Empordà, s’han herboritzat diversos tàxons singulars que completen algunes de les aportacions ja publicades anteriorment (Font et al., 1998). En aquest treball se cita per primer cop al Principat la composta Evax lusitanica. La resta detàxons són novetats per a aquestes comarques o bé suposen l’herborització recent d’espècies citades de molt antic que no havien estat indicades darrerament i que en alguns casos suposen les úniques o darreres localitats conegudes a Catalunya

Temozolomide combined with bevacizumab in metastatic melanoma. A multicenter phase II trial (SAKK 50/07)

Background: Single agent DTIC is the standard therapy for metastatic melanoma (MM) with response rates of 5−20%. Temozolomide (Tem) as an oral drug has shown equal efficacy in phase III trials. Preclinical models have shown an inhibitory effect for bevacizumab (Bev) on the proliferation of melanoma cells as well as on sprouting endothelial cells. Therefore, a therapeutic approach that combines angiogenesis inhibitors with cytotoxic agents may provide clinical benefit in MM. Methods: Design: Multicenter phase II trial. Primary endpoint: Clinical benefit (CR, PR and SD) at 12 weeks; secondary endpoints: best overall response by RECIST, response duration, progression free survival, adverse events, survival after 6 months and overall survival. Sample size was calculated according to Simon's two stage optimal design (5% significance level and 80% power) with an overall sample size of 62 patients (pts) to test H0: 20% versus H1: 35% rate of clinical benefit. Response assessment was done every 6 weeks (3 cycles). Eligibility: Stage IV MM, ECOG PS 0−2, no prior treatment for metastatic disease. Treatment regimen: One cycle consisted of Tem at 150 mg/m2 days 1−7 po and Bev at 10 mg/kg day 1 over 30 min iv and was repeated every 2 weeks until progression or unacceptable toxicity. Results: Between January 2008 and April 2009, 62 pts (40 male/22 female) at a median age of 61 years (range 30−86) with stage IV (M1a:4, M1b:12, M1c:46) melanoma were enrolled in 9 centers. The first 50 pts, who received 415 cycles are included in this interim report. The overall response rate was 26% (CR: 1 pt, PR: 12 pts; PR not confirmed yet in 3 pts), and 44% (22 pts) had stable disease over 1.5−7.5 months (median: 3). Only 30% (15 pts) had disease progression at the first evaluation at week 6. The hematological grade 3/4 toxicities according to NCI CTAE 3.0 were thrombocytopenia 10% (5 pts), neutropenia 8% (4 pts), lymphopenia and leucocytopenia each 2% (1 pt). Cumulative non-hematological toxicities grade 3/4 were nausea and fatigue each 6% (3 pts), hypertension, vomiting and hemorrhage, each 4% (2 pts), thrombosis/embolism, infection, constipation, anorexia, elevation of alkaline phosphatase, bilirubin, GGT, ALT and AST each 2% (1 pt). Conclusion: In metastatic melanoma the combination of Tem/Bev is a safe regimen with a promising efficacy and few grade 3/4 toxicities. Updated results of all 62 pts will be presented.

26/7/19, remise de décorations à la caserne des Célestins [boulevard Henri IV, 4e arrondissement] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 55173

26/7/19, le colonel commandant la Garde Républicaine remet des décorations [à la caserne des Célestins, boulevard Henri IV, 4e arrondissement] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 55177